Yin, Jiale, Author at MediaMedic

2024 CASH | Professor Lei Zhang : Gene Therapy Based on AAV Vector Brings Hope for Cure to Hemophilia Patients

By Yin, Jiale 2024.01.26

From January 5th to 7th, 2024, the 4th China/Academy of Hematology Sciences Development Conference (CASH) was grandly held in Tianjin. Continuing with the theme "Comprehensive Hematology, Healthcare, and Wellness", this…

2024 CASH丨Professor Jun Shi : Gene Therapy for β-Thalassemia Using Lentiviral Vectors

By Yin, Jiale 2024.01.26

β-thalassemia is a hereditary blood disorder caused by mutations in the β-globin gene, leading to impaired synthesis or structural changes in β-globin. Gene therapy for β-thalassemia using lentiviral vectors refers…

2024 CASH | Professor Jun Ma : From ASH to CASH, the Mission of Serving Patients and Strengthening Innovation Remains Unchanged

By Yin, Jiale 2024.01.26

Organized by the China Medical Science Academy Peking Union Medical College and co-hosted by the Hematology Hospital of the China Medical Science Academy (Institute of Hematology), the 4th Chinese Hematology…

2024 CASH | ProfessorJianXiang Wang : Innovating Research and Standardizing Quality Control to Promote the Healthy Development of Hematology in China

By Yin, Jiale 2024.01.26

Editor's Note Welcoming a new chapter in hematology, the Fourth China Hematology Development Conference (CASH), organized by the Peking Union Medical College of the Chinese Academy of Medical Sciences and…

2024 CASH | Professor Hui Wei : Nurturing Growth in AML Treatment with Spring Breeze, Looking Forward to the Future of Immunotherapy

By Yin, Jiale 2024.01.26

Acute Myeloid Leukemia (AML), a group of malignancies originating from hematopoietic stem cells, stands as the most prevalent hematologic malignancy and has always been a focal point in both basic…

2024 CASH | Professor Gang An : Continuous Innovation in CAR-T Therapy, A New Dawn in MM Treatment!

By Yin, Jiale 2024.01.26

The Fourth China Hematology Development Conference was held in Tianjin from January 5th to 7th, 2024. Themed "Broadening Hematology, Healthcare, and Wellness," the conference focused on the core development directions…

2024 CASH | Professor ChunYan Ji : Significant Advances in Leukemia Treatment, Aiming to Achieve Treatment-Free Remission for More Patients

By Yin, Jiale 2024.01.26

Leukemia is a serious disease that poses a significant threat to public health, characterized by high mortality rates and challenging treatments. Fortunately, recent years have witnessed remarkable progress in the…

SABCS 2023丨An Interview with Dr. Santiago Escriva-de-Romanion the Novel Zaniratamab Combinations for HR+/HER2+ mBC

By Yin, Jiale 2024.01.25

Editor's Note: At the 2023 SABCS congress, We interviewed with Dr. Santiago Escriva-de-Romani from Vall d’Hebron Institute of Oncology (VHIO), explored the revolutionary advancements in breast cancer treatment, focusing on the introduction of the…

SABCS 2023丨Treatment Approach for Leptomeningeal Carcinomatosis in Advanced Breast Cancer Patients: Antibody-Drug Conjugate Trastuzumab Deruxtecan

By Yin, Jiale 2024.01.25

Editor's Note: The antibody-drug conjugate trastuzumab deruxtecan (T-DXd) has demonstrated significant activity in the treatment of in patients with advanced breast cancer (ABC), and as a result, it is widely…

Tumor Cell-Released Kynurenine Biases MEP Differentiation into Megakaryocytes in Individuals with Cancer: A Novel Mechanism for Thrombocytosis and Erythrocytopenia

By Yin, Jiale 2024.01.22

In December 2023, a study led by Professor Bo Huang and his team from the Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, was published in the prestigious international…